Written by Klarity Editorial Team
Published: Jun 11, 2026

If you’re a psychiatrist or PMHNP thinking about adding insomnia treatment to your telehealth practice, you’ve probably hit the same wall: Can I even prescribe sleep meds remotely? What about controlled substances? Do I need to see patients in-person first?
The short answer: Yes, you can prescribe insomnia medications via telehealth right now — including controlled substances like Ambien (zolpidem) and temazepam — through at least the end of 2026. But the rules differ dramatically by state, and what works for a California PMHNP with full practice authority looks nothing like the reality for a Texas NP who needs physician delegation.
Let’s cut through the regulatory fog and talk about what actually matters for building a sustainable telehealth insomnia practice.
Here’s the baseline: The DEA has extended COVID-era telemedicine flexibilities through December 31, 2026. This means you can prescribe Schedule II–V controlled substances to new patients via telehealth without an initial in-person exam, as long as you’re following federal and state law.
Before 2020, the Ryan Haight Act required an in-person medical evaluation before prescribing any controlled substance via telemedicine. During the pandemic, that requirement was waived. The DEA has now extended that waiver four times — most recently on December 31, 2025 — specifically to prevent massive disruptions in patient care while they finalize permanent telehealth regulations.
What this means for insomnia treatment:
The catch: These are temporary rules. The DEA is working on a permanent framework that will likely require a ‘Special Registration’ for telehealth prescribing of controlled substances. Under the proposed rules announced in January 2025, any DEA-registered practitioner could obtain a Telemedicine Special Registration to prescribe Schedule III–V substances remotely. Schedule II would require an Advanced Telemedicine Registration available only to certain specialists — including psychiatrists.
For now, you operate under the extension. But you should be ready for a new registration requirement sometime in 2026 or early 2027.
As a board-certified psychiatrist, you have full prescriptive authority in every state for insomnia treatment. No supervision required, no scope-of-practice limitations, no collaborative agreements. Insomnia is squarely within psychiatric practice — especially when it co-occurs with anxiety, depression, or other mental health conditions (which it usually does).
You can:
The only regulatory hurdles are state-specific:
If you’re a psychiatric nurse practitioner, your ability to practice independently and prescribe controlled substances depends entirely on your state’s scope-of-practice laws.
Full Practice Authority States (Best for NP Independence):
Reduced Practice States (Require Collaboration):
Restricted Practice States (Physician Supervision Required):
Bottom line for NPs: If you’re in New York, Illinois, or California with the required experience, you can run an independent telehealth insomnia practice. In Texas, Florida, or Pennsylvania, you’ll need a collaborating physician — which adds complexity but doesn’t make it impossible.
What you can do:
What you must do:
The reality: California has huge demand and generally supports telehealth. The state’s parity laws mean insurance covers telehealth mental health at the same rate as in-person. If you’re targeting underserved areas (Central Valley, rural Northern California), you’ll find patients.
What you can do:
What you cannot do:
What you must do:
The nuance: Texas’s ban on telehealth controlled substances applies specifically to chronic pain. Insomnia is not pain management. As long as you’re documenting this as psychiatric/mental health treatment, you’re clear. Just don’t accidentally code it as pain-related.
What you can do:
What you cannot do:
What you must do:
The business case: Florida’s telehealth provider registration is a major advantage. You can serve Florida patients without going through full state licensure if you’re registered elsewhere. But you must frame insomnia care as psychiatric treatment to prescribe sleep medications legally.
What you can do:
What you must do:
The opportunity: New York has a severe psychiatrist shortage, especially upstate. Experienced PMHNPs who’ve hit that 3,600-hour threshold can fill a massive gap. The state strongly supports telehealth — parity laws are robust, Medicaid coverage is solid, and both audio-video and audio-only visits are reimbursed for mental health.
What you can do:
What you must do:
The challenge: Pennsylvania has no comprehensive telehealth statute yet (attempts at legislation have stalled). But in practice, the state medical and nursing boards accept telehealth as equivalent to in-person care if standard-of-care is met. Just document thoroughly.
What you can do:
What you must do:
The upside: Illinois has some of the most progressive NP laws in the country. Downstate Illinois (outside Chicago) has significant provider shortages. If you’re an experienced PMHNP with FPA, you can build an independent telehealth insomnia practice and serve patients across the state.
Most dedicated insomnia medications are Schedule IV controlled substances:
Non-benzodiazepine hypnotics (‘Z-drugs’):
Benzodiazepines (short-acting):
Orexin receptor antagonists:
Non-controlled options (no special telehealth restrictions):
The regulatory focus is on Schedule IV. These require:
Here’s what most provider marketing gets wrong: they quote unrealistic patient acquisition costs like ‘$30–50 per patient’ through DIY marketing. The reality is much more expensive.
DIY Marketing Costs (What They Don’t Tell You):
Total monthly marketing spend for a solo or small group practice trying to fill their schedule: $3,000–5,000+ with uncertain results.
The Klarity Model:
The ROI comparison: Instead of gambling $3,000–5,000/month on marketing channels that might not work, you pay only when a qualified patient books with you. That’s guaranteed ROI versus uncertain marketing outcomes.
Multi-state practice requires multi-state licensing. Prioritize:
You need a separate DEA registration for each state where you’re prescribing controlled substances. Some states also require a state-level controlled substance license (Illinois, California, etc.).
Every state has mandatory PDMP checks before prescribing controlled substances. Requirements vary:
Sign up for each state’s system and integrate it into your workflow.
Nearly every state now mandates e-prescribing for controlled substances. You’ll need:
Telehealth prescribing of controlled substances will face more scrutiny than in-person. Your documentation should include:
The current DEA extension expires December 31, 2026. Before then, expect new permanent regulations requiring:
Special Registration for Telehealth Prescribing:
Enhanced PDMP Integration:
Standard-of-Care Requirements:
For insomnia providers, the key question: Will the permanent rules require an eventual in-person exam for ongoing telehealth controlled substance treatment?
The DEA’s current proposal suggests no — the Special Registration pathway is designed to allow purely remote prescribing relationships. But details matter, and you should monitor this closely in 2026.
If you’re a psychiatrist: This is a clear opportunity. You can practice in any state where you’re licensed, prescribe the full range of insomnia medications, and differentiate yourself from primary care providers who may be less comfortable managing psychiatric comorbidities.
If you’re a PMHNP in a full-practice state (New York, Illinois, California with experience): You have essentially the same scope as a psychiatrist for insomnia treatment. You can build an independent practice and fill a massive access gap.
If you’re an NP in a restricted state (Texas, Florida, Pennsylvania): You’ll need a collaborating physician, but that’s a logistical challenge, not a dealbreaker. Many telehealth platforms (including Klarity) provide the physician collaboration framework so you can focus on patient care.
The market reality: Insomnia affects 30% of adults. Most never get treatment. Primary care doctors are uncomfortable prescribing sleep medications long-term. Psychiatrists and PMHNPs are uniquely positioned to manage both the insomnia and the psychiatric conditions that often cause or worsen it.
The business model that works: Instead of spending thousands per month on marketing and hoping patients find you, join a platform that handles patient acquisition and delivers pre-qualified patients to your schedule. You control your hours, see the patients you want to see, and only pay when someone actually books.
That’s the advantage of a marketplace model over trying to build your own patient pipeline from scratch.
Klarity Health connects psychiatrists and PMHNPs with patients seeking insomnia treatment across the country. We handle:
You handle what you do best: clinical care.
Learn more about joining Klarity’s provider network → [kalarityhealth.com/providers]
Can I prescribe Ambien (zolpidem) via telehealth without seeing the patient in person first?
Yes, through at least December 31, 2026, under the current DEA extension. You must conduct a proper video evaluation, check your state’s PDMP, and document the clinical rationale. This applies in all states, though some (like Florida) require the treatment to be for a ‘psychiatric disorder’ rather than just insomnia as a medical condition.
Do PMHNPs need a collaborating physician to prescribe sleep medications?
It depends on your state. In New York (after 3,600 hours), Illinois (after 4,000 hours with FPA), and California (with AB 890 experience requirements), you can prescribe independently. In Texas, Florida, and Pennsylvania, you need physician collaboration or supervision.
Which states have the most restrictions on telehealth prescribing of controlled substances?
Texas bans telehealth controlled substances for chronic pain management (but allows it for psychiatric conditions like insomnia). Florida bans telehealth controlled substances except for psychiatric treatment, inpatient/hospice, and nursing homes. Most other states defer to federal DEA rules.
Do I need to check the PDMP every time I prescribe a sleep medication?
Requirements vary by state:
What happens when the DEA telehealth extension expires at the end of 2026?
The DEA is expected to implement a permanent ‘Special Registration’ system before the extension expires. You’ll likely need to apply for a Telemedicine Special Registration to continue prescribing Schedule III–V controlled substances remotely. Watch for updates in late 2026.
Can I treat insomnia patients in multiple states via telehealth?
Yes, but you need:
How do I code insomnia treatment for insurance billing?
Use DSM-5 diagnosis code F51.01 (Primary Insomnia Disorder) or G47.00 (Insomnia, unspecified) depending on the clinical presentation. Bill appropriate telehealth CPT codes (99213–99215 for established patient visits, 99203–99205 for new patients, with telehealth modifier). Always document comorbid psychiatric conditions if present (anxiety, depression), as these strengthen the case for psychiatric treatment billing.
Federal Regulations:
U.S. Drug Enforcement Administration. ‘DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care.’ Press Release, December 31, 2025. www.dea.gov
U.S. Drug Enforcement Administration. ‘DEA Announces Three New Telemedicine Rules to Continue Open Access to Critical Care.’ Press Release, January 16, 2025. www.dea.gov
Healthcare Finance News. ‘Telehealth Prescribing of Controlled Drugs Extended Through 2025.’ Susan Morse, November 18, 2024. www.healthcarefinancenews.com
DLA Piper. ‘DEA and HHS Issue Third Temporary Extension of Telemedicine Flexibilities.’ November 2024. www.dlapiper.com
State-Specific Sources:
Florida Statutes §456.47 – Use of Telehealth to Provide Services. Florida Legislature. www.leg.state.fl.us
Florida Statutes §464.012 – Nurse Practice Act, APRN Prescribing Authority. Florida Legislature, 2024 Edition. www.flsenate.gov
Texas Board of Nursing. ‘Advanced Practice Registered Nurse Practice FAQs.’ Current webpage (accessed 2026). www.bon.texas.gov
New York State Education Department, Office of the Professions. ‘Nurse Practitioner Professional Practice Requirements.’ Updated 2022. www.op.nysed.gov
Pennsylvania Department of Health. ‘Prescription Drug Monitoring Program Q&A.’ Act 191 of 2014 (ABC-MAP). www.pa.gov
Pennsylvania General Assembly. ‘Act 191 of 2014 – Achieving Better Care by Monitoring All Prescriptions Program (ABC-MAP) Act.’ www.legis.state.pa.us
Illinois Department of Financial & Professional Regulation. ‘Nursing Licensure Information – APN Controlled Substance License.’ idfpr.illinois.gov
California Board of Registered Nursing. ‘AB 890 – Nurse Practitioner Practice Without Standardized Procedures.’ Effective 2023. rn.ca.gov
California Department of Justice. ‘Controlled Substance Utilization Review and Evaluation System (CURES) – PDMP.’ oag.ca.gov
RxAgent Compliance Portal. ‘California PDMP Requirements.’ rxagent.co
Find the right provider for your needs — select your state to find expert care near you.